Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2026

Conditions

Parkinson Disease

Interventions

DRUG

Citalopram 20mg

20mg daily

DRUG

Placebo

matching placebo pills

Trial Locations (1)

University of Michigan, Ann Arbor

All Listed Sponsors

collaborator

National Institute on Aging (NIA)

NIH

lead

University of Michigan

OTHER